Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) is a common and often debilitating mental health condition characterized by persistent and excessive worry or anxiety about various aspects of life.

GAD affects approximately 3-5% of the global population, making it one of the most prevalent mental health disorders worldwide.

GAD's journey from a misunderstood state of stress to a recognized severe condition underscores an escalating demand for innovative solutions.

3%

of the US population is affected

 

 

 

The annual total economic burden of GAD in the US:

$42

billion

 

 

43%

of individuals with GAD receive treatment

 

 

 

Our clinical team has over

120

years of combined experience

 

Download Our Paper

Fill out this form to download our white paper on how to overcome the biggest obstacles in conducting a clinical trial for Generalized Anxiety Disorder

iNGENuCRO_GeneralizedAnxietyDisorderInnovation

 

For US biotechs, the evolving understanding of GAD not only unveils a significant market but also a chance to pioneer in a field where the need for effective interventions has never been greater. Embracing this challenge means not just developing new treatments but reshaping mental health care's future, establishing leadership in a competitive arena.